Submitted by Anonymous (not verified) on
Product Form
Tablet for suspension
API Generic 1
rilpivirine
API Strength 1
2.5
Patent Expiration
Patent Number
  • US 7125879
  • US 8101752
  • US 8618291
  • US 11065198
Sub Title
EDURANT